Ann Arbor, MI - October 2015 - ENDRA Life Sciences ( announced today that Jing Gao, MD, has joined the company as a Scientific Advisor. Dr. Gao is currently Research Assistant Professor of Radiology at Weill Cornell Medicine in New York, NY. Dr. Gao brings over 30 years of clinical and research experience in abdominal ultrasound, in both the U.S and China.

Dr. Gao completed her medical education at Changchun and Dalian Medical Colleges in China. Besides her post at Cornell, Dr. Gao is also Deputy President and guest professor at The Dalian University International Institute of Medical Imaging, in China.

Her numerous honors and professional affiliations include being named one of China’s Top 100 Ultrasound Physicians by the Chinese Association of Medical Imaging Technology. She is a Fellow of the Chinese Association of Ultrasound in Medicine and Biology, a Fellow of the American Institute of Ultrasound in Medicine, and an Editorial Board Member of Clinical Imaging (Elsevier).

Dr. Gao has over 35 peer reviewed publications in the areas of liver, spleen and kidney diseases and quantitative ultrasound imaging.

“Dr. Gao’s deep understanding of abdominal ultrasound applications in the U.S and Asia will be enormously valuable to ENDRA as we introduce our thermo-acoustic systems to global clinical markets.” said Francois Michelon, ENDRA’s CEO and Board Chairman.

About ENDRA Life Sciences

ENDRA Life Science’s mission is to bring new capabilities to ultrasound.

ENDRA’s Photo-Acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. ENDRA is proud to have a growing global installed base of leading institutions using the Nexus 128 system, the only fully 3D imaging solution for imaging anatomy, physiology and labeled molecular targets.

ENDRA’s Thermo-Acoustic technology will enable clinicians to use their existing ultrasound equipment to clearly visualize tissue health, function and composition – at the point of care. This directly aligns with current healthcare trends to improve patient access, clinical effectiveness, safety and cost.


ENDRA Life Sciences